OBJECTIVE: To examine the hospital variability in use of red blood cells (RBCs), fresh-frozen plasma (FFP), and platelet transfusions in patients undergoing major noncardiac surgery. BACKGROUND: Blood transfusion is commonly used in surgical procedures in the United States. Little is known about the hospital variability in perioperative transfusion rates for noncardiac surgery. METHODS: We used the University HealthSystem Consortium database (2006-2010) to examine hospital variability in use of allogeneic RBC, FFP, and platelet transfusions in patients undergoing major noncardiac surgery. We used regression-based techniques to quantify the variability in hospital transfusion practices and to study the association between hospital characteristics and the likelihood of transfusion. RESULTS: After adjusting for patient risk factors, hospital transfusion rates varied widely for patients undergoing total hip replacement (THR), colectomy, and pancreaticoduodenectomy. Compared with patients undergoing THR in average-transfusion hospitals, patients treated in high-transfusion hospitals have a greater than twofold higher odds of being transfused with RBCs [adjusted odds ratio (AOR) = 2.41; 95% confidence interval (CI), 1.89-3.09], FFP (AOR = 2.81; 95% CI, 2.02-3.91), and platelets (AOR = 2.52; 95% CI, 1.95-3.25), whereas patients in low-transfusion hospitals have an approximately 50% lower odds of receiving RBCs (AOR = 0.45; 95% CI, 0.35-0.57), FFP (AOR = 0.37; 95% CI, 0.27-0.51), and platelets (AOR = 0.42; 95% CI, 0.29-0.62). Similar results were obtained for colectomy and pancreaticoduodenectomy. CONCLUSIONS: There was dramatic hospital variability in perioperative transfusion rates among patients undergoing major noncardiac surgery at academic medical centers. In light of the potential complications of transfusion therapy, reducing this variability in hospital transfusion practices may result in improved surgical outcomes.
OBJECTIVE: To examine the hospital variability in use of red blood cells (RBCs), fresh-frozen plasma (FFP), and platelet transfusions in patients undergoing major noncardiac surgery. BACKGROUND: Blood transfusion is commonly used in surgical procedures in the United States. Little is known about the hospital variability in perioperative transfusion rates for noncardiac surgery. METHODS: We used the University HealthSystem Consortium database (2006-2010) to examine hospital variability in use of allogeneic RBC, FFP, and platelet transfusions in patients undergoing major noncardiac surgery. We used regression-based techniques to quantify the variability in hospital transfusion practices and to study the association between hospital characteristics and the likelihood of transfusion. RESULTS: After adjusting for patient risk factors, hospital transfusion rates varied widely for patients undergoing total hip replacement (THR), colectomy, and pancreaticoduodenectomy. Compared with patients undergoing THR in average-transfusion hospitals, patients treated in high-transfusion hospitals have a greater than twofold higher odds of being transfused with RBCs [adjusted odds ratio (AOR) = 2.41; 95% confidence interval (CI), 1.89-3.09], FFP (AOR = 2.81; 95% CI, 2.02-3.91), and platelets (AOR = 2.52; 95% CI, 1.95-3.25), whereas patients in low-transfusion hospitals have an approximately 50% lower odds of receiving RBCs (AOR = 0.45; 95% CI, 0.35-0.57), FFP (AOR = 0.37; 95% CI, 0.27-0.51), and platelets (AOR = 0.42; 95% CI, 0.29-0.62). Similar results were obtained for colectomy and pancreaticoduodenectomy. CONCLUSIONS: There was dramatic hospital variability in perioperative transfusion rates among patients undergoing major noncardiac surgery at academic medical centers. In light of the potential complications of transfusion therapy, reducing this variability in hospital transfusion practices may result in improved surgical outcomes.
Authors: Matthew A Warner; David A Woodrum; Andrew C Hanson; Darrell R Schroeder; Gregory A Wilson; Daryl J Kor Journal: Mayo Clin Proc Date: 2016-08 Impact factor: 7.616
Authors: Sara L Zettervall; Peter A Soden; Dominique B Buck; Jack L Cronenwett; Phillip P Goodney; Mohammad H Eslami; Jason T Lee; Marc L Schermerhorn Journal: J Vasc Surg Date: 2016-11-23 Impact factor: 4.268
Authors: Matthew A Warner; David Woodrum; Andrew Hanson; Darrell R Schroeder; Gregory Wilson; Daryl J Kor Journal: Transfusion Date: 2017-01-28 Impact factor: 3.157
Authors: Oliver M Theusinger; Stephanie L Kind; Burkhardt Seifert; Lain Borgeat; Christian Gerber; Donat R Spahn Journal: Blood Transfus Date: 2014-04 Impact factor: 3.443
Authors: Christopher T Aquina; Neil Blumberg; Christian P Probst; Adan Z Becerra; Bradley J Hensley; James C Iannuzzi; Maynor G Gonzalez; Andrew-Paul Deeb; Katia Noyes; John R T Monson; Fergal J Fleming Journal: J Gastrointest Surg Date: 2015-08-12 Impact factor: 3.452
Authors: Matthew A Warner; Qing Jia; Leanne Clifford; Gregory Wilson; Michael J Brown; Andrew C Hanson; Darrell R Schroeder; Daryl J Kor Journal: Transfusion Date: 2015-11-11 Impact factor: 3.157
Authors: David C Fitzgerald; Annie N Simpson; Robert A Baker; Xiaoting Wu; Min Zhang; Michael P Thompson; Gaetano Paone; Alphonse Delucia; Donald S Likosky Journal: J Thorac Cardiovasc Surg Date: 2020-05-13 Impact factor: 5.209